Willow Biosciences Inc
TSX:WLLW
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Willow Biosciences Inc
Other Non-Cash Items
Willow Biosciences Inc
Other Non-Cash Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Non-Cash Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Willow Biosciences Inc
TSX:WLLW
|
Other Non-Cash Items
CA$327k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-60%
|
CAGR 10-Years
N/A
|
|
|
B
|
Bright Minds Biosciences Inc
CNSX:DRUG
|
Other Non-Cash Items
CA$2.9m
|
CAGR 3-Years
65%
|
CAGR 5-Years
78%
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Other Non-Cash Items
$14m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
X
|
Xenon Pharmaceuticals Inc
NASDAQ:XENE
|
Other Non-Cash Items
$63.1m
|
CAGR 3-Years
34%
|
CAGR 5-Years
58%
|
CAGR 10-Years
20%
|
|
|
Eupraxia Pharmaceuticals Inc
TSX:EPRX
|
Other Non-Cash Items
CA$10.5m
|
CAGR 3-Years
54%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
e
|
enGene Holdings Inc
NASDAQ:ENGN
|
Other Non-Cash Items
$7.8m
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Willow Biosciences Inc
Glance View
Willow Biosciences, Inc. is a biotechnology company. The company is headquartered in Calgary, Alberta and currently employs 49 full-time employees. The company went IPO on 2017-09-14. The firm's products include tetrahydrocannabinol (THC), cannabidiol (CBD), cannabidivarin (CBDV), cannabigerovarin (CBGV), tetrahydrocannabivarin (THCV) and cannabinol (CBN). The firm has two laboratories for research and development in Mountain View, California and Burnaby, British Columbia. In addition, the Company has an analytical testing lab in Burnaby where it provides third-party analytical testing and product development services to the cannabis industry through its subsidiary Willow Analytics Inc. The company also offers testing for all forms of cannabis products, including flower, concentrates and extracted ingredients.
See Also
What is Willow Biosciences Inc's Other Non-Cash Items?
Other Non-Cash Items
327k
CAD
Based on the financial report for Mar 31, 2025, Willow Biosciences Inc's Other Non-Cash Items amounts to 327k CAD.
What is Willow Biosciences Inc's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 5Y
-60%
Over the last year, the Other Non-Cash Items growth was 3 170%.
